Alliancebernstein L.P. Has $2.08 Million Stake in Alere Inc. (ALR)

Alliancebernstein L.P. raised its position in Alere Inc. (NYSE:ALR) by 33.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 52,377 shares of the medical research company’s stock after buying an additional 13,250 shares during the period. Alliancebernstein L.P.’s holdings in Alere were worth $2,081,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Choate Investment Advisors raised its stake in shares of Alere by 21.0% in the first quarter. Choate Investment Advisors now owns 94,532 shares of the medical research company’s stock worth $3,756,000 after buying an additional 16,393 shares during the last quarter. Asset Management One Co. Ltd. raised its stake in shares of Alere by 0.5% in the first quarter. Asset Management One Co. Ltd. now owns 15,940 shares of the medical research company’s stock worth $633,000 after buying an additional 79 shares during the last quarter. Cornerstone Capital Management Holdings LLC. raised its stake in shares of Alere by 35.3% in the first quarter. Cornerstone Capital Management Holdings LLC. now owns 442,597 shares of the medical research company’s stock worth $17,584,000 after buying an additional 115,575 shares during the last quarter. Clinton Group Inc. raised its stake in shares of Alere by 153.6% in the first quarter. Clinton Group Inc. now owns 54,942 shares of the medical research company’s stock worth $2,183,000 after buying an additional 33,279 shares during the last quarter. Finally, OMERS ADMINISTRATION Corp raised its stake in shares of Alere by 12.1% in the first quarter. OMERS ADMINISTRATION Corp now owns 408,600 shares of the medical research company’s stock worth $16,234,000 after buying an additional 44,100 shares during the last quarter. Institutional investors and hedge funds own 90.57% of the company’s stock.

Alere Inc. (ALR) opened at 50.32 on Wednesday. The stock’s 50 day moving average price is $49.99 and its 200-day moving average price is $44.17. Alere Inc. has a 12 month low of $31.47 and a 12 month high of $50.50. The stock’s market cap is $4.40 billion.

ILLEGAL ACTIVITY NOTICE: This report was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this report can be viewed at https://sportsperspectives.com/2017/07/19/alliancebernstein-l-p-has-2-08-million-stake-in-alere-inc-alr.html.

A number of equities research analysts have issued reports on the company. BidaskClub lowered Alere from a “buy” rating to a “hold” rating in a research note on Sunday. Zacks Investment Research upgraded Alere from a “sell” rating to a “hold” rating in a research note on Tuesday, June 27th. Canaccord Genuity lowered Alere from a “buy” rating to a “hold” rating and set a $51.00 price target for the company. in a research note on Tuesday, June 6th. Jefferies Group LLC reiterated a “hold” rating and issued a $51.00 price target on shares of Alere in a research note on Thursday, June 1st. Finally, BTIG Research reiterated a “hold” rating on shares of Alere in a research note on Wednesday, May 24th. Seven investment analysts have rated the stock with a hold rating, The company currently has an average rating of “Hold” and an average target price of $48.00.

About Alere

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Institutional Ownership by Quarter for Alere (NYSE:ALR)

Receive News & Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply